Publications Database

Bradstreet J. J. et al. (2010)

Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.

Alternative Medicine Review

15(1), pp. 15-32

Read Abstract (New Window) Read Full (New Window)

Bradstreet J. J. et al. (2007)

Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders.

Medical Hypotheses

68(5), pp. 979-987

Read Abstract (New Window) Read Full (New Window)

Frye R. E. et al. (2013)

A review of traditional and novel treatments for seizures in autism spectrum disorder: Findings from a systematic review and expert panel.

Frontiers in Public Health

Read Abstract (New Window) Read Full (New Window)

Frye R. E. et al. (2013)

Cerebral folate receptor autoantibodies in autism spectrum disorder.

Molecular Autism

18 pp. 369–381.

Read Abstract (New Window)

Frye R. E. , Rossignol D. A. (2016)

Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes.

Clinical Medicine Insights: Pediatrics

Read Abstract (New Window) Read Full (New Window)

Frye R. E. , Rossignol D. A. (2014)

Treatments for biomedical abnormalities associated with autism spectrum disorder.

Frontier in Pediatrics

eCollection 2014.

Read Abstract (New Window) Read Full (New Window)

Rossignol D. A. , Frye R. E. (2012)

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

Molecular Psychiatry

17 pp. 389-401

Read Full (New Window)

Rossignol D. A. (2007)

Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism.

Medical Hypotheses

68(6), pp. 1208-1227

Read Abstract (New Window)

Rossignol D. A. et al. (2012)

Hyperbaric oxygen treatment in autism spectrum disorders.

Medical Gas Research

15(2), pp. 16

Read Abstract (New Window) Read Full (New Window)

Rossignol D. A. , Frye R. E. (2014)

Melatonin in autism spectrum disorders.

Current Clincial Pharmacology

9(4), pp. 326-334.

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2011)

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

Developmental Medicine and Child Neurology

53(9), pp. 783-792

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2012)

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Molecular Psychiatry

17(3), pp. 290-314.

Read Abstract (New Window)

Rossignol D. A. (2009)

Novel and emerging treatments for autism spectrum disorders: a systematic review.

Annals of Clinical Psychiatry

21(4), pp. 213-236

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2014)

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Frontier in Pediatrics

August, 2

Read Abstract (New Window) Read Full (New Window)